| |
Unique opportunity for international press to interact directly
with world’s hottest biotech firms
San Diego, CA, and Munich, Germany, February
7, 2007: On Monday, March 5, the first-ever BIO-Europe
Spring will open its doors at the Milano Convention Center (MIC)
in Italy. The three day conference (March 5-7) promises to be exciting as
deal- and decision makers from across the globe meet at the pre-eminent
springtime partnering conference for the biotechnology industry.
Like its conference counterpart, BIO-Europe, which is held in the
Autumn, BIO-Europe Spring will be an important focal point for companies
seeking to identify new business opportunities and strike deals to
drive future business. The conference, organized by EBD Group, will
feature many notable industry leaders such as Rob Wills, VP of Alliance
Management at Johnson & Johnson; Judith Hills, VP of Corporate
and Business Development for Licensing, Europe, Japan & Asia Pacific,
at Bristol-Myers Squibb; and Roger Longman, Managing Partner of Windhover
Information. These and other speakers will cover a wide range
of trends, issues and technologies that are shaping the industry’s
future
The conference will also feature a proprietary online partnering system
through which participants can set up individual meetings with potential
partners—thus providing an unbeatable opportunity for direct
engagement between individuals from all parts the biotechnology value
chain.
EBD Group, the organizer of the BIO-Europe Spring and BIO-Europe partnering
conferences, expects more than 1,000 attendees to attend the conference—which
should become one of the world’s premier international partnering
events for biotechnology and the life sciences. Since 1993, EBD Group’s
conferences have provided annual partnering fora for networking, sharing
research and innovations and striking deals. Today, the BIO-Europe
conferences are the largest and most comprehensive international life
science partnering events in the world.
Highlights of the BIO-Europe
Spring conference sessions include:
- Rethinking the Biotech-Pharma Partnering Model: Will
the whole ever be worth more than the sum of its parts?
- Next Generation Companies: With increasing competition
for late-stage assets, pharmaceutical companies are taking a greater
interest in earlier stage biotech companies. In keeping with
this trend, some of the most exciting early-stage players of the
biotech industry will make their pitches to the conference’s
elite audience.
- Pink Biotech, The Convergence of White and Red Biotech: New
enabling technologies are transforming the industry and cost-advantages
linked to disruptive technologies are already a reality. BIO-Europe
Spring will explore how the convergence of White and Red biotech
will play a key role in helping both early and late-stage companies
overcome industry challenges.
- Future of Mid-sized Pharma: Globalization is profoundly
affecting the biotechnology industry-- and especially mid-sized pharma
companies. This session explores the unique opportunities and challenges
confronting mid-sized firms and discusses optimal ways to navigate
the globalization trend.
Partnering System Goes Live:
The web-based conference partnering system is now live and registered
attendees can access it at www.ebdgroup.com/bioeuropespring/partnering.htm.
As at all EBD Group conferences, BIO-Europe Spring leverages the
organizer’s proprietary state-of-the-art web-based partnering
software platform. The partnering system enables all participants
to quickly query a comprehensive database in order to identify and
engage with many potential partners during the conference. The partnering
system also allows journalists to arrange meetings and interviews
in advance of the conference. Two-hundred booths will be available
for one-on-one meetings. In addition, a quiet interview room
in the BIO-Europe Europe press office can be booked on site. Delegates’ meeting
schedules will be made available on personal log-in pages on the
BIO-Europe Spring website in the days prior to the conference.
Notes to Editors:
The conference’s press office will actively disseminate evolving
news, stories, and conference themes to journalists. Entry to BIO-Europe
Spring is free to the media, as is full access to the partnering system,
sessions, press conferences, workshops, and pre-arranged partnering
meetings. Attending journalists will also receive a complimentary delegate
pack, including the complete conference handbook. Visit the BIO-Europe
Spring conference website at www.ebdgroup.com/bes/registration.htm for
detailed information on this year’s conference and online registration.
When you register online, please write
into the comment field within the registration form that you are requesting
a complimentary press registration. Please fax a copy of your press
pass to complete your complimentary media registration to fax number
+49 (89) 23 88 756 - 55.
About EBD Group
EBD Group is the leading partnering firm for the global biotechnology
industry. Since 1993, firms in the life sciences have leveraged EBD
Group’s partnering conferences, technology and services to identify
business opportunities and develop strategic relationships that drive
their business.
EBD Group’s conferences (run in collaboration with leading industry
partners and international trade associations such as BIO and Eucomed)
include BIO-Europe, the world’s largest stand-alone life science
partnering conference; BIO-Europe Spring; the investor conference,
BioEquity Europe (co-organized with BioCentury Publications); and the
convergent medical technology partnering conference, BioDevice Partnering. EBD’s
novel, web-based, partnering software system is also used at numerous
third-party events around the world. Outside of the conference format,
EBD Group’s consultants can provide hands-on assistance for firms
seeking to in- or out-license products and technologies.
EBD Group has offices in San Diego, Munich and London. For more information
visit www.ebdgroup.com or www.bioeuropespring.com for
conference related issues.
If you are interested in attending the conference,
or require further information, please contact:
Constantine
Theodoropulos
Boston Communications
Direct: +1 ( 617) 619 9801
Cell: +1 ( 617) 816 4637
Fax: +1 ( 617) 507 5354
constantine@prboston.com |
| :::::::::::::::::::::::::::::::::::::::::::::::::::::: |
Anita
Harris
Boston Communications
Direct: +1 (617) 576 0906
anita.harris@comcast.net |
|
|